PYPD Stock Price | PolyPid P/E, Revenue, EPS, & Forecasts

PolyPid • PYPD

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About PolyPid

Ticker

PYPD

Trading on

NASDAQ

ISIN

IL0011326795

Industry

Biotechnology

Sector

Healthcare

CEO

Dikla Czaczkes Akselbrad

Headquarters

18 Hasivim Street, Petah Tikva, undefined, Israel, 4959376

Employees

Website

polypid.com

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Metrics

BasicAdvanced

Market cap

$33.7M

P/E ratio

EPS

-$4.24

Dividend Yield

0.00%

Beta

1.25

Forward P/E ratio

EBIDTA

$-27.7M

Ex dividend date

Price & volume

Market cap

$33.7M

Average daily volume

1.4M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

392.23

Earnings

EPS

-$4.24

EPS estimate (current quarter)

-$0.82

EPS estimate (next quarter)

-$0.51

EBITDA

$-27.7M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.25

52-week High

$4.49

52-week Low

$2.30

50-day moving average

$2.87

200-day moving average

$3.10

Short ratio

0.92

Short %

0.49%

Management effectiveness

ROE (TTM)

-853.05%

ROA (TTM)

-86.72%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

10.2M

Float

4.6M

Insiders %

25.65%

Institutions %

49.51%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$12.75

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.25

-$1.30

3.85%

Q2 • 24Beat

-$1.22

-$1.02

-19.61%

Q3 • 24Missed

-$1.07

-$0.88

-22.08%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-8.5M

-∞%

Q4 • 24

$0M

$-8.3M

-∞%

Q1 • 25

NaN%

-2.96%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$25.2M

$17.5M

69.53%

Q4 • 24

$16.8M

99.49%

Q1 • 25

-33.19%

-4.41%

43.08%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

Q4 • 24

Q1 • 25

NaN%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a PolyPid share?

PolyPid shares are currently traded for undefined per share.

How many shares does PolyPid have?

PolyPid currently has 10.2M shares.

Does PolyPid pay dividends?

No, PolyPid doesn't pay dividends.

What is PolyPid 52 week high?

PolyPid 52 week high is $4.49.

What is PolyPid 52 week low?

PolyPid 52 week low is $2.30.

What is the 200-day moving average of PolyPid?

PolyPid 200-day moving average is $3.10.

Who is PolyPid CEO?

The CEO of PolyPid is Dikla Czaczkes Akselbrad.

How many employees PolyPid has?

PolyPid has 57 employees.

What is the market cap of PolyPid?

The market cap of PolyPid is $33.7M.

What is the P/E of PolyPid?

The current P/E of PolyPid is null.

What is the EPS of PolyPid?

The EPS of PolyPid is -$4.24.

What is the PEG Ratio of PolyPid?

The PEG Ratio of PolyPid is null.

What do analysts say about PolyPid?

According to the analysts PolyPid is considered a buy.